Micropep Technologies is thrilled to announce the successful completion of a $29 million funding round aimed at advancing their groundbreaking work in the field of plant biotechnology. Recognized for their innovative approach, Micropep focuses on developing next-generation biological crop protection solutions through the application of micropeptides—short natural peptide molecules that are engineered to target and regulate specific plant genes and proteins. This substantial investment will enable Micropep to accelerate its research and development efforts, enhancing the efficacy and sustainability of agricultural practices while responding to the growing global demand for safe and environmentally friendly pest management options. The funding will be instrumental in expanding Micropep's product pipeline, bolstering partnerships with agricultural stakeholders, and advancing regulatory approvals to bring their pioneering solutions to market more swiftly. As agricultural challenges intensify worldwide, with a pressing need for sustainable practices that reduce dependence on chemical pesticides, Micropep stands at the forefront of transformation in the industry. The investment underscores the confidence of our investors in our vision of harnessing the power of nature to create effective and sustainable crop protection methods. With this support, Micropep Technologies is poised to redefine agricultural practices and contribute significantly to food security, making it an exciting time for the company as we embark on this crucial journey towards innovative and eco-friendly agriculture.
Tech Innovation in Agriculture: Micropep Technologies Secures $29 Million in Series B Funding Round
Recently funded · $29.0M Series bAgriculture
Get the full Micropep Technologies company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
